June 8, 2023, 10:55 AM
June 8, 2023, 10:55 AM
The Departmental Health Service (Sedes) cConfirmed the ninth death from influenza A H1N1 in Santa Cruz. The victim is a 65-year-old woman who had an underlying pathology, but she had not received the vaccine that protects against complications of the disease.
The Secretary of Health of the Government, Edil Toledo, pointed out that he is concerned that deaths from this disease continue to increase. “Unfortunately there is a victim who did not have the vaccine eitherThat’s what worries us,” Toledo said.
In this sense, the health authority insisted on the call to assist vaccination centers that are applying the dose to people from vulnerable groups: children from six months to 12 yearsolder adults, pregnant women and people with underlying diseases.
Toledo insisted that the vaccine prevents complications that can lead to death, even more so if they are people with chronic diseases. The statistical data thus demonstrates why the nine deaths registered so far correspond to people without a vaccine and with pre-existing diseases.
Two of them had diabetes, two had heart disease, two had kidney disease, and the rest had other serious illnesses. Some of them also developed serious lung problems. Eight of those affected were over 65 years of age.
According to Toledo, the epidemic of influenza A H1N1 registered a slow decline, unlike two weeks ago when the growth was sustained and reached a peak. However, there are still concerns about the positivity rate and the lethality that is 0.52%.
In what of the year they add up 1,723 positive cases in department cRuceño and the majority was reported in the capital municipality.
The Headquarters data also show that the age group most affected by infections are young people and young adults.
Of the more than 1,700 registered positive cases Up to now, 672 occurred in people between the ages of 21 and 50, which represents 41.5%.
The Centers for Disease Control and Prevention (CDC) conducts studies every year to determine the efficacy of the vaccine against this disease.
While dose protection may vary, recent studies have shown that it reduces the risk of getting sick in cause of influenza between 40% and 60% in the population Generally, during seasons when most circulating viruses are an exact match to the viruses used in influenza vaccines.
In general, current vaccines work best against influenza viruses B and influenza A H1N1 and offer less protection against influenza A H3N2 viruses.
Between 2019 and 2020, vaccination prevented 7.5 million cases of influenza in the US, 3.7 million medical consultations associated with this flu, 105,000 hospitalizations and 6,300 deaths.
